iopromide has been researched along with Obesity in 2 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pan, YN | 1 |
Li, AJ | 1 |
Chen, XM | 1 |
Wang, J | 1 |
Ren, DW | 1 |
Huang, QL | 1 |
Schummer, C | 1 |
Sakr, Y | 1 |
Steenbeck, J | 1 |
Gugel, M | 1 |
Reinhart, K | 1 |
Schummer, W | 1 |
1 review available for iopromide and Obesity
Article | Year |
---|---|
Risk of extravasation after power injection of contrast media via the proximal port of multilumen central venous catheters: case report and review of the literature.
Topics: Adult; Catheterization, Central Venous; Contrast Media; Extravasation of Diagnostic and Therapeutic | 2010 |
1 trial available for iopromide and Obesity
Article | Year |
---|---|
Coronary Computed Tomographic Angiography at Low Concentration of Contrast Agent and Low Tube Voltage in Patients with Obesity:: A Feasibility Study.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Coronary Artery Disease; Feasi | 2016 |